171 International survey: Effects of cumulative exposure to corticosteroids in patients with eczema, including topical steroid withdrawal syndrome (TSWS)

Abstract

Patients with eczema have a lifetime of exposure to corticosteroids (topical (TCS), oral (OCS), inhaled, nasal sprays etc). The survey examined cumulative effects of corticosteroid exposure, sociodemographic characteristics, disease attributes, history of eczema treatment, and experience and knowledge of topical steroid withdrawal syndrome (TSWS). Surveyed total lifetime corticosteroid use of all types. 91% reported TCS use with an average duration of 15.3 years, applying 1-2 times daily, for 15-30 days a month, on an average body surface area (BSA) of 24%.